Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?

To: Stephen M. DeMoss who wrote (741)	3/16/1998 11:28:00 AM
From: Michael Paul Langley	Read Replies (1) \| Respond to of 1055

Monday March 16, 10:53 am Eastern Time Company Press Release Theragenics Announces a 2-For-1 Stock Split NORCROSS, Ga.--(BUSINESS WIRE)--March 16, 1998--Theragenics Corporation (NASDAQ:THRX - news), the Atlanta-based cancer treatment producer, today announced that its board of directors approved a 2-for-1 stock split, payable April 15 to shareholders of record March 31. After the split, Theragenics will have about 29.1 million shares outstanding. Christine Jacobs, Theragenics' president and chief executive officer, said, ''Theragenics' stock price increased 91% during 1996, 59% during 1997 and 77% so far this year, based on consistently excellent performance by the Company. We decided to split our stock to improve its trading liquidity and to help ensure that it trades in a range that is accessible to a broad base of investors.'' Theragenics Corporation, based in Norcross, Ga., is the manufacturer of TheraSeed(R) a rice-sized device used in the treatment of localized prostate cancer with a one-time, minimally invasive procedure. For additional information on the Company, call Theragenics' Investor Relations Department at 800/998-8479. The Company's common stock is traded on the NASDAQ Stock Market under the symbol THRX. -------------------------------------------------------------------------------- Contact: Theragenics Corporation Ron Warren Director of Investor Relations phone 800/998-THRX (8479) or 770/381-8338